Table 1 Study population
Parameter | HIV-uninfected | HIV-infected on ART | HIV-infected viremic | |||
|---|---|---|---|---|---|---|
Active | Placebo | Active | Placebo | Active | ||
n = 16 | n = 4 | n = 12 | n = 3 | n = 13 | ||
Age in years, mean (range) | 28 (19–48) | 25 (19–28) | 44 (27–62) | 44 (29–56) | 31 (20–51) | |
Male, n (%) | 6 (38) | 3 (75) | 10 (83) | 3 (100) | 12 (92) | |
Years since HIV diagnosis, mean (range) | 14 (1–27) | 15 (6–27) | 3 (0–20) | |||
Absolute CD4+ T-cell count, median (IQR) | 706 (530–838) | 738 (708–757) | 568 (494–920) | |||
HIV-1 RNA (copies ml–1) on day 0, median (IQR) | High VL, n = 9 | 21,040 (9,660–28,990) | ||||
Low VL, n = 4 | 270 (185–550) | |||||
